Skip to main content

Table 1 miRNAs in cancer therapeutics

From: Novel approaches in cancer treatment: preclinical and clinical development of small non-coding RNA therapeutics

Target

Drug name

Cancer

Phase

ClinicalTrials.gov Identifier

Mir 16

TargomiRs

Malignant pleura mesothelioma, Non small-cell lung cancer

I

NCT02369198

Mir 155

MRG 106

Lymphomas, Leukemia

I

NCT02580552

Mir 34a

MRX34

Melanoma, Primary liver cancer; Hematologic malignancies

I Terminated

NCT01829971

Mir 34a

MRX34

Melanoma, Primary liver cancer; Hematologic malignancies

I/II Withdrawn

NCT02862145